SCHEMBL6671091

SCHEMBL6671091

COc1cccc(OC)c1NC(=O)c1ccc(Oc2c(Cl)cc(C)c3c2CCC3(C)C)o1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR4 O95977 12/20 0.47
▸ S1PR2 O95136 8/20 0.47
▸ S1PR3 Q99500 5/20 0.47
▸ S1PR5 Q9H228 4/20 0.47
▸ S1PR1 P21453 2/20 0.47
▸ GNRHR P30968 2/20 0.43
▸ FPR1 P21462 1/20 0.43
▸ GPR183 P32249 1/20 0.43
▸ GPR119 Q8TDV5 1/20 0.43
▸ CACNA1F O60840 1/20 0.41
▸ CHRM4 P08173 1/20 0.41
▸ ADORA3 P0DMS8 1/20 0.41
▸ CHRM1 P11229 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ DRD1 P21728 1/20 0.41
▸ DRD4 P21917 1/20 0.41
▸ SLC6A2 P23975 1/20 0.41
▸ HRH2 P25021 1/20 0.41
▸ TACR1 P25103 1/20 0.41
▸ PTAFR P25105 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5266515 0.82 S1PR4 (0.46) S1PR4S1PR2S1PR3S1PR5S1PR1
SCHEMBL6665757 0.80 GNRHR (0.51) S1PR4S1PR2S1PR3S1PR5S1PR1
SCHEMBL6667035 0.79 GNRHR (0.45) S1PR4S1PR2S1PR3S1PR5S1PR1
SCHEMBL6672151 0.78 GNRHR (0.44) S1PR4S1PR2S1PR3S1PR5S1PR1
SCHEMBL6688513 0.76 GNRHR (0.48) S1PR4S1PR2S1PR3S1PR5S1PR1
Acetic Acid SCHEMBL6666594 0.76 GNRHR (0.69) GNRHRCACNA1FCHRM4ADORA3CHRM1
SCHEMBL6668919 0.75 GNRHR (0.52) S1PR4S1PR2S1PR3S1PR5S1PR1
SCHEMBL5264281 0.74 FPR1 (0.44) S1PR4S1PR2S1PR3S1PR5S1PR1
SCHEMBL6663296 0.74 GNRHR (0.51) S1PR4S1PR2S1PR3S1PR5S1PR1
SCHEMBL6668435 0.74 GNRHR (0.57) S1PR4S1PR2S1PR3S1PR5S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401427-A4 NON-PEPTIDE GNRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM AGOURON PHARMA (US) 2004-12-01 — — EP disclosed
EP-1401427-A2 NON-PEPTIDE GNRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM Agouron Pharmaceuticals, Inc. (US) 2004-03-31 — — EP disclosed
WO-2002098363-A2 NON-PEPTIDE GnRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM AGOURON PHARMACEUTICALS, INC. (US) 2002-12-12 — — WO disclosed
Send feedback